An exclusivity agreement is stopping Liquidia Corporation from gaining full FDA approval of its new inhalation powder for pulmonary arterial hypertension. The company said it is disappointed with the agency's decision and plans to "take quick action."

Physicians using the Paradise Ultrasound Renal Denervation system from Recor Medical or Symplicity Spyral Renal Denervation system from Medtronic will soon be eligible for a much more significant reimbursement when treating Medicare patients in an inpatient setting. 

Grocery stores have started selling more and more plant-based meat alternatives in recent years, and early evidence suggests replacing even some meat with these products may be beneficial. Researchers did note that more studies on this subject are still needed.

Researchers explored data from 23 different studies, identifying a “positive and almost linear association” between alcohol consumption and hypertension. 

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

The group wants countries to implement population-wide changes that can keep salt intake to a minimum. It estimates that such policies could save up to 900,000 lives in just a few years. 

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms. 

Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.